Astra Zeneca Investors Lobby For Management Shakeup

Fierce Pharma has;

Astra Zeneca Investors Lobby For Management Shakeup

April 9, 2012 | By Tracy Staton

The knives are out at AstraZeneca ($AZN). Investors are agitating for big changes at the troubled drugmaker, even asking for a new CEO, the Financial Times reports. Despairing over the company's recent "downward spiral," some shareholders are lobbying for CFO Simon Lowth to take David Brennan's job, while others back the company's commercial VP, Tony Zook.

But Bernstein Research analyst Jack Scannell thinks a more radical switch is necessary. "You don't need a lawyer or a marketing person," Scannell told FT. "You either need Attila the Hun--a total butcher--to run it down until it can be bought, or a Paul Janssen-like figure: a successful scientist who can really take on the research team."

Analysts have offered up other ideas for reversing AstraZeneca's recent slide: Buy a company, such as Amylin Pharmaceuticals ($AMLN), for instance. But the company's big shareholders figure that new deals need new management.

With a new chairman in the offing--ex-Volvo chief Leif Johansson is running for election--a shake-up could well follow. "The board will probably step in and take a new strategic direction because the company is in a downward spiral," one shareholder said.

- read the story in the FT

​Related Articles:
AstraZeneca scouts new drug deals to silence a chorus of critics
Who's next to move on Amylin? Analysts say Big Pharma looms
AZ's Brennan nabs 11% pay hike to $5.89M
Is AZ aiming for a Forest buy?

Thank You Fierce Pharma and Ms Staton

This is an Outrage. How DARE Astra Zeneca pay Brennan a paltry $5.89 Million.

Brennan's Seroquel has killed more than TWICE as many consumers as J&J Weldon's Risperdal.

https://www.rxisk.org/Research/DrugInformation.aspx?DrugID=4220&ProductDrugID=11319&ProductName=SEROquel#6_10011906_0_0_0

And the Diabetes?

https://www.rxisk.org/Research/DrugInformation.aspx?DrugID=4220&ProductDrugID=11319&ProductName=SEROquel#6_10012601_0_0_0

Shame, Shame on those stingy bean counters at Astra Zeneca.

Look at J&J Weldon's numbers

Death:

https://www.rxisk.org/Research/DrugInformation.aspx?DrugID=3180&ProductDrugID=1259&ProductName=RisperDAL#6_10011906_0_0_0

Diabetes

https://www.rxisk.org/Research/DrugInformation.aspx?DrugID=3180&ProductDrugID=1259&ProductName=RisperDAL#6_10012601_0_0_0

And all Brennan gets is a measly $5.89 Million? Why, his product is Vastly superior at bashing some Billing Clerk's Political Illnesses into Disability, Diseases and Death than Weldon's is, except that Weldon/J&J's Janssen were the ringleaders of the TMAP gang which unleashed Both of these useless, killer drugs upon an unsuspecting America.

Shearlings Got Ploughed has;

Mr Weldon's Walk Away Golden Parachute Numbers

$197 Million to Mr Risperdal, to leave as CEO and become Chairman of the Board.

And just a piddly little $5.89 Million to Mr Seroquel.

David ought to go ask Bill if he'd like to share, the same way our CINC expects all of Us to Share through the application of Government Force and Fraud, so that Both David and Bill can continue sharing the good life, after killing so many other people for committing Thought and Mood Crimes.